Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating benign prostatic hyperplasia

A technology of prostatic hyperplasia and composition, which is applied in the directions of drug combination, pharmaceutical formula, plant raw material, etc., can solve the problems of insignificant curative effect, large toxic and side effects, etc., and achieve the effect of exact curative effect and small toxic and side effects.

Inactive Publication Date: 2014-05-14
陈磊
View PDF2 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

It has the disadvantages of inconspicuous curative effect and large toxic and side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0048] A Chinese medicinal composition for treating benign prostatic hyperplasia, which is made of the following raw materials by weight: 15 parts of astragalus, 15 parts of yam, 15 parts of pangolin, 12 parts of sage, 12 parts of salvia, 12 parts of talc, 12 parts of achyranthes, Rehmannia glutinosa 12 parts, dianthus 12 parts, dandelion 12 parts, Liu Jinu 7 parts, seaweed 7 parts, forsythia 7 parts, plantain 7 parts, green bark 7 parts, single living 7 parts, white grass root 7 parts, phellodendron 7 parts , 7 servings of Polygonum cuspidatum, 3 servings of Wang Buliu Xing, 3 servings of Cinnamon, 3 servings of Gallus gallus domesticus, 3 servings of Rat Fu, 3 servings of Amber.

[0049] The preparation method is: according to the conventional traditional Chinese medicine preparation method, the oral medicine suitable for medicinal use is prepared.

Embodiment 2

[0051] A Chinese medicinal composition for the treatment of prostate hyperplasia, which is made of the following raw materials in parts by weight: 13 parts of astragalus, 13 parts of Chinese yam, 13 parts of pangolin, 11 parts of sage, 11 parts of salvia, 11 parts of talc, 11 parts of Achyranthes Rehmannia glutinosa 11 parts, dianthus 11 parts, dandelion 11 parts, Liu Jinu 6 parts, seaweed 6 parts, forsythia 6 parts, plantain 6 parts, green peel 6 parts, single living 6 parts, white grass root 6 parts, phellodendron 6 parts , 6 parts of Polygonum cuspidatum, 2 parts of Wang Buliu Xing, 2 parts of Cinnamon, 2 parts of Gallus gallus domesticus, 2 parts of Rat Fu, 2 parts of Amber.

[0052] The preparation method is: according to the conventional traditional Chinese medicine preparation method, the oral medicine suitable for medicinal use is prepared.

Embodiment 3

[0054] A traditional Chinese medicine composition for the treatment of prostate hyperplasia, which is made of the following raw materials by weight: 17 parts of astragalus, 17 parts of yam, 17 parts of pangolin, 13 parts of sage, 13 parts of salvia, 13 parts of talc, 13 parts of achyranthes, Rehmannia glutinosa 13 parts, dianthus 13 parts, dandelion 13 parts, Liu Jinu 8 parts, seaweed 8 parts, forsythia 8 parts, plantain 8 parts, green bark 8 parts, single living 8 parts, white grass root 8 parts, phellodendron 8 parts , 8 parts of Polygonum cuspidatum, 4 parts of Wang Buliu Xing, 4 parts of Cinnamon, 4 parts of Gallus gallus domesticus, 4 parts of Rat Fu, 4 parts of Amber.

[0055] The preparation method is: according to the conventional traditional Chinese medicine preparation method, the oral medicine suitable for medicinal use is prepared.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a pharmaceutical composition for treating benign prostatic hyperplasia. The pharmaceutical composition comprises, by weight, 13-17 parts of radix astragali, 13-17 parts of Chinese yam, 13-17 parts of pangolin, 11-13 parts of polygonum aviculare, 11-13 parts of salvia miltiorrhiza, 11-13 parts of talc, 11-13 parts of achyranthes bidentata, 11-13 parts of prepared rehmannia roots, 11-13 parts of dianthus superbus, 11-13 parts of dandelion, 6-8 artemisia anomata, 6-8 parts of algae, 6-8 parts of fructus forsythiae, 6-8 parts of semen plantaginis, 6-8 parts of pericarpium citri reticulatae viride, 6-8 parts of radix angelicae tuhuo, 6-8 parts of lalang grass rhizome, 6-8 parts of golden cypress, 6-8 parts of polygonum cuspidatum, 2-4 parts of the seeds of cowherb, 2-4 parts of cinnamon, 2-4 parts of gizzard pepsin, 2-4 parts of pillworm, and 2-4 parts of amber. The pharmaceutical composition has the advantages of being definite in curative effect, and little in toxic and side effect.

Description

Technical field [0001] The present invention relates to the technical field of traditional Chinese medicine, in particular to a traditional Chinese medicine composition for treating benign prostatic hyperplasia. Background technique [0002] Prostatic hyperplasia is one of the common diseases of male elderly, and the incidence is increasing with the aging of the global population. The clinical symptoms of benign prostatic hyperplasia are mainly manifested as frequent urination, dysuria, urinary retention and hematuria, etc. The incidence increases with age, but there may not be clinical symptoms when there is hyperplasia. There are many studies on the pathogenesis of prostate hyperplasia, but the etiology has not yet been clarified. It is currently known that prostate hyperplasia must have two conditions for the presence of testicles and age. In recent years, with the deepening of basic research, it is believed that prostate hyperplasia is the result of the interaction between ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/899A61P13/08A61K33/12A61K35/10A61K35/36A61K35/37A61K35/64A61K35/57A61K35/63
Inventor 陈磊
Owner 陈磊
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com